Turner KM - Search Results

1

ASO Practice Guidelines Series: Management of Resectable, Borderline Resectable, and Locally Advanced Pancreas Cancer.

Turner KM, Wilson GC, Patel SH, Ahmad SA. Turner KM, et al. Ann Surg Oncol. 2024 Mar;31(3):1884-1897. doi: 10.1245/s10434-023-14585-y. Epub 2023 Nov 19. Ann Surg Oncol. 2024. PMID: 37980709 Review.

2

Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.

Unruh D, Turner K, Srinivasan R, Kocatürk B, Qi X, Chu Z, Aronow BJ, Plas DR, Gallo CA, Kalthoff H, Kirchhofer D, Ruf W, Ahmad SA, Lucas FV, Versteeg HH, Bogdanov VY. Unruh D, et al. Int J Cancer. 2014 Jan 1;134(1):9-20. doi: 10.1002/ijc.28327. Epub 2013 Jul 27. Int J Cancer. 2014. PMID: 23754313 Free PMC article.

3

Low-Risk Non-mucinous Adenocarcinoma of the Appendix: When Is an Appendectomy Enough?

Turner KM, Patel SH. Turner KM, et al. Ann Surg Oncol. 2022 Apr;29(4):2144-2145. doi: 10.1245/s10434-021-11229-x. Epub 2022 Jan 10. Ann Surg Oncol. 2022. PMID: 35006507 No abstract available.

4

Radiation therapy in borderline resectable pancreatic cancer: A review.

Turner KM, Delman AM, Kharofa JR, Smith MT, Choe KA, Olowokure O, Wilson GC, Patel SH, Sohal D, Ahmad SA. Turner KM, et al. Surgery. 2022 Jul;172(1):284-290. doi: 10.1016/j.surg.2021.12.013. Epub 2022 Jan 13. Surgery. 2022. PMID: 35034793 Review.

5

Is endocrine and exocrine function improved following duodenal preserving pancreatic head resection over whipple for chronic pancreatitis?

Turner KM, Delman AM, Johnston Ii ME, Hanseman D, Wilson GC, Ahmad SA, Patel SH. Turner KM, et al. HPB (Oxford). 2022 Jul;24(7):1194-1200. doi: 10.1016/j.hpb.2021.12.021. Epub 2022 Jan 4. HPB (Oxford). 2022. PMID: 35090793 Free article.

6

ASO Author Reflections: An Underappreciated Metric: Systemic Chemotherapy Dose Density in Pancreatic Cancer.

Turner KM, Patel SH. Turner KM, et al. Ann Surg Oncol. 2022 Jun;29(6):3473-3474. doi: 10.1245/s10434-022-11390-x. Epub 2022 Feb 6. Ann Surg Oncol. 2022. PMID: 35128600 No abstract available.

7

Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?

Turner KM, Delman AM, Vaysburg DM, Kharofa JR, Smith MT, Choe KA, Olowokure O, Sohal D, Wilson GC, Ahmad SA, Patel SH. Turner KM, et al. Ann Surg Oncol. 2022 Jun;29(6):3463-3472. doi: 10.1245/s10434-022-11363-0. Epub 2022 Feb 9. Ann Surg Oncol. 2022. PMID: 35141802

8

ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer.

Turner KM, Patel SH. Turner KM, et al. Ann Surg Oncol. 2022 Mar 30. doi: 10.1245/s10434-022-11650-w. Online ahead of print. Ann Surg Oncol. 2022. PMID: 35353256 No abstract available.

9

Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?

Turner KM, Delman AM, Ammann AM, Sohal D, Olowokure O, Choe KA, Smith MT, Kharofa JR, Ahmad SA, Wilson GC, Patel SH. Turner KM, et al. Ann Surg Oncol. 2022 Mar 31. doi: 10.1245/s10434-022-11580-7. Online ahead of print. Ann Surg Oncol. 2022. PMID: 35357614

10

A National Assessment of T2 Staging for Intrahepatic Cholangiocarcinoma and the Poor Prognosis Associated with Multifocality.

Turner KM, Delman AM, Kharofa J, Olowokure O, Sohal D, Quillin RC, Shah SA, Ahmad SA, Patel SH, Wilson GC. Turner KM, et al. Ann Surg Oncol. 2022 Aug;29(8):5094-5102. doi: 10.1245/s10434-022-11762-3. Epub 2022 Apr 20. Ann Surg Oncol. 2022. PMID: 35441906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters